Biotech

All Articles

Pfizer takes $230M struck after axing fell short DMD gene therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failing has actually gone a $230...

AC Immune observes 'spots' possible in Alzheimer's medication records

.After much more than 20 years of work with neurodegenerative health conditions, Swiss biotech hvac ...

GSK drops ph. 2 HPV vaccine over shortage of best-in-class possible

.GSK has ditched a phase 2 human papillomavirus (HPV) vaccination from its own pipe after choosing t...

OS Treatments refiles $6M IPO to finance HER2 medication, preclinical ADCs

.Operating system Therapies will certainly provide on the NYSE American sell substitution this morni...

ALX's fizzling CD47 action fee delivers inventory spiraling down

.ALX Oncology's period 2 stomach cancer response rate has actually diminished. After observing its C...

Ionis axes eye condition from intendeds of Roche-partnered possibility after data let down

.One More of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed assumptions,...

Biogen's chief executive officer mentioned no high-risk handle 2023. He prepares to be daring

.While Biogen's pharma peers are searching for late-stage possessions along with little danger, CEO ...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Biography has been a biotech trying to find a pipeline after it junked its lead resources ov...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually handed back civil rights to an early Alzheimer's illness plan to Denali Therapi...

Takeda touches new mind of US oncology company-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...